National Deed Agreement
21/09/2026
A new national agreement between Health New Zealand and Aotearoa Clinical Trials Trust (ACTT) makes it easier to bring more clinical trials to more New Zealand hospitals.
Read moreLatest News
Peninsula Medical Centre Joins the ACTT Network as a Satellite Research Site
07/09/2026
Aotearoa Clinical Trials (ACTT) is pleased to welcome Peninsula Medical Centre (ACTT - Peninsula) as a satellite research site within its growing network, strengthening the delivery of clinical research in primary healthcare settings and expanding opportunities for participation in clinical trials across Auckland, New Zealand.
Read more
Global clinical trial reveals safest, most effective antibiotics for Staphylococcus aureus bloodstream infections
19/06/2026
Aotearoa New Zealand researchers and clinicians have contributed to a major international clinical trial that is set to change how Staphylococcus aureus bloodstream infections are treated worldwide.
Read more
CLINICAL LINK
14/05/2026
ACTT’s quarterly update for our sponsors, partners and collaborators. Sharing key milestones, research activity, business growth, opportunities to engage, and the collective impact made possible through our work together.
Read more
#TalkResearch - April 2026 | Newsletter No.1
14/05/2026
Despite ongoing global uncertainty, Aotearoa Clinical Trials remains firmly focused on its mission to bring more novel clinical trials and therapies to the communities we serve across Aotearoa New Zealand. Our continued commitment to quality has been recognised, with our sites achieving the highest level of accreditation from the International Accreditation Agency for Clinical Research (IAOCR).
Read more
ACTT Demonstrates Continued Excellence with IAOCR Gold Accreditation
28/04/2026
Independently accredited to global standards, ACTT’s IAoCR Gold Accreditation reflects our commitment to high-quality clinical research delivery.
Read more
#TALK Research - December Newsletter
11/12/2025
As the end of the year approaches, it is encouraging to reflect on ACTT’s strong performance across a broad range of therapeutic areas. Our involvement in cutting-edge research, including modern CRISPR therapies for rare diseases and inherited cholesterol disorders, and next generation of triple agonists in the metabolic space – continues to put Aotearoa on the map.
Read more
2025 ACTT Annual Report
15/10/2025
We are proud to introduce our 2025 Annual Report highighting the work and outcomes of the last year.
Read more